Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Epilepsy Drugs Market


6. Market Share – Global Epilepsy Drugs

6.1 By Country
6.2 By Drugs Category
6.3 By Drugs


7. Country - Global Epilepsy Drugs Market Analysis

7.1 United States
7.2 United Kingdom
7.3 France
7.4 Germany
7.5 Italy
7.6 Spain
7.7 India
7.8 China
7.9 Japan


8. Drugs Category - Global Epilepsy Drugs Market Analysis

8.1 First Generation
8.2 Second Generation
8.3 Third Generation
8.4 Others


9. Drugs - Global Epilepsy Drugs Market Analysis

9.1 Vimpat (Lacosamide)
9.2 Keppra (Levetiracetam)
9.3 Sabril (Vigabatrin)
9.4 Onfi (Clobazam)
9.5 Fycompa
9.6 Briviact (Brivaracetam)
9.7 Epidiolex
9.8 Cenobamate (YKP3089)
9.9 Others


10. Company Analysis

10.1 Eisai Co., Ltd.

10.1.1 Overview
10.1.2 Recent Development
10.1.3 Sales Analysis

10.2 UCB Inc.

10.2.1 Overview
10.2.2 Recent Development
10.2.3 Sales Analysis

10.3 H. Lundbeck A/S

10.3.1 Overview
10.3.2 Recent Development
10.3.3 Sales Analysis

10.4 GW Pharmaceuticals Plc.

10.4.1 Overview
10.4.2 Recent Development
10.4.3 Sales Analysis



List of Figures

Figure-01: Global Epilepsy Drugs Market (Million US$), 2017 – 2020
Figure-02: Forecast for – Global Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-03: United States – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-04: United States – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-05: United Kingdom – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-06: United Kingdom – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-07: France – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-08: France – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-09: Germany – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-10: Germany – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-11: Italy – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-12: Italy – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-13: Spain – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-14: Spain – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-15: India – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-16: India – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-17: China – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-18: China – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-19: Japan – Epilepsy Drugs Market (Million US$), 2016 – 2020
Figure-20: Japan – Forecast for Epilepsy Drugs Market (Million US$), 2021 – 2027
Figure-21: Drugs Category – First Generation Market (Million US$), 2016 – 2020
Figure-22: Drugs Category – Forecast for First Generation Market (Million US$), 2021 – 2027
Figure-23: Drugs Category – Second Generation Market (Million US$), 2016 – 2020
Figure-24: Drugs Category – Forecast for Second Generation Market (Million US$), 2021 – 2027
Figure-25: Drugs Category – Third Generation Market (Million US$), 2016 – 2020
Figure-26: Drugs Category – Forecast for Third Generation Market (Million US$), 2021 – 2027
Figure-27: Drugs Category – Others Market (Million US$), 2016 – 2020
Figure-28: Drugs Category – Forecast for Others Market (Million US$), 2021 – 2027
Figure-29: Drugs – Vimpat (Lacosamide) Market (Million US$), 2016 – 2020
Figure-30: Drugs – Forecast for Vimpat (Lacosamide) Market (Million US$), 2021 – 2027
Figure-31: Drugs – Keppra (Levetiracetam) Market (Million US$), 2016 – 2020
Figure-32: Drugs – Forecast for Keppra (Levetiracetam) Market (Million US$), 2021 – 2027
Figure-33: Drugs – Sabril (Vigabatrin) Market (Million US$), 2016 – 2020
Figure-34: Drugs – Forecast for Sabril (Vigabatrin) Market (Million US$), 2021 – 2027
Figure-35: Drugs – Onfi (Clobazam) Market (Million US$), 2016 – 2020
Figure-36: Drugs – Forecast for Onfi (Clobazam) Market (Million US$), 2021 – 2027
Figure-37: Drugs – Fycompa Market (Million US$), 2016 – 2020
Figure-38: Drugs – Forecast for Fycompa Market (Million US$), 2021 – 2027
Figure-39: Drugs – Briviact (Brivaracetam) Market (Million US$), 2016 – 2020
Figure-40: Drugs – Forecast for Briviact (Brivaracetam) Market (Million US$), 2021 – 2027
Figure-41: Drugs – Epidiolex Market (Million US$), 2018 – 2020
Figure-42: Drugs – Forecast for Epidiolex Market (Million US$), 2021 – 2027
Figure-43: Drugs – Cenobamate (YKP3089) Market (Million US$), 2019 – 2020
Figure-44: Drugs – Forecast for Cenobamate (YKP3089) Market (Million US$), 2021 – 2027
Figure-45: Drugs – Others Market (Million US$), 2016 – 2020
Figure-46: Drugs – Forecast for Others Market (Million US$), 2021 – 2027

List of Tables

Table-01: Global Epilepsy Drugs Market Share by Country (Percent), 2017 – 2020
Table-02: Forecast for – Global Epilepsy Drugs Market Share by Country (Percent), 2021 – 2027
Table-03: Global Epilepsy Drugs Market Share by Drugs Category (Percent), 2017 – 2020
Table-04: Forecast for – Global Epilepsy Drugs Market Share by Drugs Category (Percent), 2021 – 2027
Table-05: Global Epilepsy Drugs Market Share by Drugs (Percent), 2017 – 2020
Table-06: Forecast for – Global Epilepsy Drugs Market Share by Drugs (Percent), 2021 – 2027